๐ฐ Christopher Recknor News
Page 2 - Christopher Recknor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Christopher Recknor. Real-time updates on events, politics, business and more.
October 8, 2021
Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.
October 7, 2021
The company also announced the appointments of Dr Christopher Recknor as senior executive vice president of Clinical Operations and Dr Nitya Ray as its...
October 7, 2021
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
October 7, 2021
VANCOUVER, Washington, Oct. 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company...
October 7, 2021
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
May 5, 2021
VANCOUVER, Washington, May 05, 2021 (GLOBE NEWSWIRE) โ CytoDyn Inc. (OTC.QB: CYDY), (โCytoDynโ or the โCompanyโ), a late-stage biotechnology company developing leronlimab (Vyrologix or PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the agreement to partner with Academic Research Organization (ARO) โ Albert Einstein Israelite Hospital (AEIH) in Sรฃo Paulo, Brazil for two COVID-19 trials. The COVID-19 trials in Brazil are intended...
May 5, 2021
The firm said the interim analysis for the critically ill batch will be done when enrollment reaches 120 patients, or 40% of the 300 patients
March 11, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.